GW&K INVESTMENT MANAGEMENT, LLC – Neurocrine Biosciences, Inc. Transaction History
GW&K INVESTMENT MANAGEMENT, LLC portfolio value:
$63.23M
portfolio value
GW&K INVESTMENT MANAGEMENT, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -3.50% | -21.58K shares | 3.09M | $106.21 | 595.32K |
Q2 2022 | share | Decrease | -9.20% | -62.53K shares | -3.56M | $97.48 | 616.90K |
Q1 2022 | share | Increase | +48.15% | 220.82K shares | 24.63M | $93.75 | 679.43K |
Q4 2021 | share | Increase | +3.32% | 14.73K shares | -3.51M | $84.63 | 458.61K |
Q3 2021 | share | Decrease | -1.22% | -5.47K shares | -1.15M | $95.91 | 443.88K |
Q2 2021 | share | Increase | +1.90% | 8.37K shares | 846K | $97.32 | 449.35K |
Q1 2021 | share | Increase | +13.87% | 53.69K shares | 5.76M | $97.25 | 440.98K |
Q4 2020 | share | Decrease | -0.47% | -1.82K shares | -295K | $95.85 | 387.28K |
Q3 2020 | share | Increase | +3.22% | 12.13K shares | -8.57M | $96.16 | 389.10K |
Q2 2020 | share | Increase | +0.88% | 3.28K shares | 13.64M | $122 | 376.96K |
Q1 2020 | share | Increase | +29.18% | 84.42K shares | 1.25M | $86.55 | 373.68K |
Q4 2019 | share | Decrease | -2.68% | -7.96K shares | 4.31M | $107.49 | 289.26K |
Q3 2019 | share | Increase | +26.17% | 61.64K shares | 6.89M | $90.11 | 297.22K |
Q2 2019 | share | Decrease | -1.34% | -3.2K shares | -1.14M | $84.43 | 235.58K |
Q1 2019 | share | Increase | +2.65% | 6.16K shares | 4.42M | $88.1 | 238.78K |
Q4 2018 | share | Increase | 0.00% | 232.62K shares | 16.61M | $71.41 | 232.62K |
Q3 2018 | share | Decrease | -100.00% | -82.14K shares | -8.07M | $122.95 | 0 |
Q2 2018 | share | Decrease | -0.42% | -350 shares | 1.22M | $98.24 | 82.14K |
Q1 2018 | share | Decrease | -9.87% | -9.03K shares | -261K | $82.93 | 82.49K |
Q4 2017 | share | Increase | +11.97% | 9.78K shares | 2.09M | $77.59 | 91.52K |
Q3 2017 | share | Decrease | -1.26% | -1.04K shares | 1.20M | $61.28 | 81.74K |
Q2 2017 | share | Decrease | -2.30% | -1.94K shares | 139K | $46 | 82.78K |
Q1 2017 | share | Decrease | -1.80% | -1.55K shares | 330K | $43.3 | 84.73K |
Q4 2016 | share | Increase | +7.70% | 6.16K shares | -718K | $38.7 | 86.28K |
Q3 2016 | share | Decrease | -6.39% | -5.47K shares | 167K | $50.64 | 80.11K |
Q2 2016 | share | Increase | +27.55% | 18.48K shares | 1.23M | $45.45 | 85.58K |
Q1 2016 | share | Increase | 0.00% | 67.1K shares | 2.65M | $39.55 | 67.1K |